Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292339 · ClinicalTrials.gov registry record · Phase 4
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
A Phase 4 study of Osteoarthritis and Tendinopathy, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 160
- Enrollment target
- 4
- Study locations
NCT05292339: Recruiting Phase 4 study of Osteoarthritis and Tendinopathy, sponsored by Emory University.
NCT05292339 is a Phase 4 study of Osteoarthritis and Tendinopathy that is actively recruiting participants, run by Emory University. The registered enrollment target is 160 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (80% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05292339, a Phase 4 study of Osteoarthritis and Tendinopathy, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 160 participants
- Enrollment target
- 4
- Study locations
Study Summary
Osteoarthritis (OA) and inflammatory conditions of the tendons and joints of the shoulder, elbow, hand, and wrist are common yet disabling diseases. Standard management utilizes conservative measures to minimize pain and improve function. Conservative pharmacological management commonly includes corticosteroid and ketorolac injections which have been well investigated as a modality of pain control and improved function in large joint OA. However, fewer studies yielding mixed results on the duration of symptomatic relief exist for arthropathy and tendinopathy of these joints. The goal of this study is to evaluate the efficacy of ketorolac and triamcinolone injections for common shoulder, elbow, wrist, and hand tendinopathy or arthropathy. Participants will be blinded to the treatment received. The duration of an individual participant's participation in this study is 24 weeks. During this time period, patients will be asked to return to the clinic for an in-person follow-up 6 weeks after the injection with either ketorolac or triamcinolone) in order to assess participants' outcomes. All work related to this project will take place at the Emory Sports Medicine Complex, Emory Executive Park, Emory Musculoskeletal Institute, the Emory University Orthopaedic and Spine Hospital, and the Emory Saint Joseph's Hospital. This study will add to existing knowledge by providing further insight into how wrist arthropathy should be most optimally and conservatively managed.
Primary Outcome
Participants will be asked to complete questionnaires to evaluate their pain at each follow-up visit. The visual analog scale or visual analog scale (VAS) is a psychometric response scale that can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. The
Conditions Studied
Interventions
- DRUG Triamcinolone injection to the shoulder, elbow, wrist, or hand
- DRUG Ketorolac injection to the shoulder, elbow, wrist, or hand
Study Locations (4)
Georgia
- Emory Saint Joseph's Hospital - Atlanta
- Emory University Orthopaedic and Spine Center - Atlanta
- 12 Executive Park Drive - Atlanta
- Emory University Orthopaedic and Spine Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-01-31 |
| Est. Completion | 2027-07 |
| Phase | Phase 4 |
What NCT05292339 shows while recruiting
NCT05292339 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Triamcinolone injection to the shoulder, elbow, wrist, or hand is the first listed.
NCT05292339 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05292339 about?
NCT05292339 is a clinical study titled "Ketorolac in Upper Extremity Tendinopathy and Arthropathy". Osteoarthritis (OA) and inflammatory conditions of the tendons and joints of the shoulder, elbow, hand, and wrist are common yet disabling diseases. Standard management utilizes conservative measures to minimize pain and improve function. Conservative pharmacological management commonly includes cor...
What is the current status of trial NCT05292339?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 160 participants. The study started on 2023-01-31. Estimated completion is 2027-07.
What conditions does trial NCT05292339 study?
This clinical trial studies the following conditions: Osteoarthritis, Tendinopathy, Arthropathy.
What interventions are being tested in trial NCT05292339?
The interventions under investigation include: Triamcinolone injection to the shoulder, elbow, wrist, or hand (DRUG), Ketorolac injection to the shoulder, elbow, wrist, or hand (DRUG).
Who is sponsoring clinical trial NCT05292339?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05292339 being conducted?
This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05292339's enrollment target sits among peer trials
160 68th of 135 higher than 67 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
RECRUITING · Phase 4
-
Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)
ACTIVE NOT RECRUITING · Phase 4
-
Duloxetine in Osteoarthritis (OA) Pain
COMPLETED · Phase 4
-
TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis
COMPLETED · Phase 4
-
Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
COMPLETED · Phase 4
-
The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI